Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Principles And Applications Of Diffusion-weighted Imaging In Cancer Detection, Staging, And Treatment Follow-up.

A. Malayeri, Riham H El Khouli, A. Zaheer, M. Jacobs, Celia P. Corona-Villalobos, I. Kamel, K. Macura
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Diffusion-weighted imaging relies on the detection of the random microscopic motion of free water molecules known as Brownian movement. With the development of new magnetic resonance (MR) imaging technologies and stronger diffusion gradients, recent applications of diffusion-weighted imaging in whole-body imaging have attracted considerable attention, especially in the field of oncology. Diffusion-weighted imaging is being established as a pivotal aspect of MR imaging in the evaluation of specific organs, including the breast, liver, kidney, and those in the pelvis. When used in conjunction with apparent diffusion coefficient mapping, diffusion-weighted imaging provides information about the functional environment of water in tissues, thereby augmenting the morphologic information provided by conventional MR imaging. Detected changes include shifts of water from extracellular to intracellular spaces, restriction of cellular membrane permeability, increased cellular density, and disruption of cellular membrane depolarization. These findings are commonly associated with malignancies; therefore, diffusion-weighted imaging has many applications in oncologic imaging and can aid in tumor detection and characterization and in the prediction and assessment of response to therapy.
This paper references
10.1148/radiol.10091367
Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Riham H Ei Khouli (2010)
10.1097/RLI.0b013e318183725e
Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy
B. Park (2008)
10.1148/radiol.10092021
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
S. Park (2010)
10.1148/radiol.10092469
Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
C. Reischauer (2010)
10.1002/jmri.22059
Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)‐enhanced MRI: Added value of diffusion‐weighted imaging (DWI)
A. Nishie (2010)
10.2214/AJR.09.3448
Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.
R. Do (2010)
10.1148/radiol.10092396
Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
H. Wang (2010)
10.1016/j.ejrad.2010.07.028
Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications.
S. Punwani (2011)
10.1002/jmri.1204
Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI
S. Partridge (2001)
10.1148/radiol.2532081718
Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?
W. Bogner (2009)
10.2214/AJR.08.1753
Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study.
R. N. Low (2009)
10.1097/RLI.0b013e3181bbdc2f
Preliminary Results for Characterization of Pelvic Lymph Nodes in Patients With Prostate Cancer by Diffusion-Weighted MR-Imaging
M. Eiber (2010)
10.1097/01.rct.0000243456.00437.59
Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results
C. Kim (2007)
10.2214/AJR.09.2436
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
K. Sandrasegaran (2009)
10.1016/j.ejrad.2009.03.054
Whole-body diffusion-weighted magnetic resonance imaging.
T. Kwee (2009)
10.1002/jmri.20251
Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate
Chiho Sato (2005)
10.1148/radiol.2463070432
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
T. Parikh (2008)
10.1016/j.eururo.2008.11.051
A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance.
N. V. van As (2009)
10.2214/AJR.09.2522
Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values.
Fernanda Philadelpho Arantes Pereira (2009)
10.1016/j.ejrad.2010.05.019
Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
C. Wang (2011)
10.1016/j.crad.2010.07.008
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
M. Costantini (2010)
10.1016/j.mric.2010.09.001
Diffusion magnetic resonance imaging of the breast.
Fernanda Philadelpho Arantes Pereira (2011)
10.1016/j.mric.2010.10.004
Diffusion MR imaging for monitoring of treatment response.
A. Padhani (2011)
10.2214/AJR.06.1403
Diffusion-weighted MRI in the body: applications and challenges in oncology.
D. Koh (2007)
10.1148/radiol.09090021
Diffusion-weighted MR imaging of the liver.
B. Taouli (2010)
10.1007/978-3-540-78576-7_14
Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.
T. Takahara (2004)
10.1097/01.RVI.0000200052.02183.92
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
I. Kamel (2006)
10.1097/01.RVI.0000227234.81718.EB
Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.
J. Deng (2006)
10.1002/jmri.20683
Artifacts and pitfalls in diffusion MRI
D. Le Bihan (2006)
10.1007/s00330-007-0847-z
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination
D. Koh (2007)
10.2214/AJR.07.3279
Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences.
M. Bruegel (2008)
10.1148/radiol.2503080995
Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
M. Sun (2009)
10.1002/jmri.21645
Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI
C. Kim (2009)
10.1259/bjr/74949757
The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI.
B. Paudyal (2010)
10.1007/s00330-004-2529-4
Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix
S. Naganawa (2004)
10.1002/jmri.10116
In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization
S. Sinha (2002)
10.1002/jmri.22235
Utility of diffusion‐weighted MRI in distinguishing benign and malignant hepatic lesions
F. Miller (2010)
10.1148/RADIOLOGY.168.2.3393671
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
D. Le Bihan (1988)
10.1002/jmri.21087
Diffusion imaging concepts for clinicians
J. Neil (2008)
10.1148/RADIOLOGY.161.2.3763909
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.
D. Le Bihan (1986)
10.1148/rg.296095521
Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications.
A. Qayyum (2009)
10.1002/jmri.21181
Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology
K. Yoshimitsu (2008)
10.2214/AJR.09.3557
Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
I. Song (2010)
10.1148/radiol.2512080880
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
B. Taouli (2009)
10.2214/AJR.09.3534
Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
S. Partridge (2010)
10.1259/BJR/24232319
Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules.
N. deSouza (2007)
10.1007/s00330-010-1999-9
Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results
S. Y. Park (2010)
10.1002/nbm.1245
Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
U. Sharma (2009)
10.1002/jmri.21412
Detection of lymph node metastasis in cervical and uterine cancers by diffusion‐weighted magnetic resonance imaging at 3T
G. Lin (2008)
10.1148/radiol.2503080874
Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
G. Lin (2009)



This paper is referenced by
10.1007/s00330-016-4663-1
T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results
Gabriel Nketiah (2016)
10.1102/1470-7330.2012.9047
Therapy response with diffusion MRI: an update
L. Bains (2012)
10.1186/s40644-020-0286-5
Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI
Silvia D Almeida (2020)
10.1007/s00261-017-1366-2
Diffusion-weighted imaging in hemorrhagic abdominal and pelvic lesions: restricted diffusion can mimic malignancy
C. Lall (2017)
10.4103/ijri.IJRI_488_17
Differentiation between benign and malignant thyroid nodules using diffusion-weighted imaging, a 3-T MRI study
L. Aghaghazvini (2018)
10.12816/0039061
Comparison of Sensitivity and Specificity of DWIBS and Contrast Enhanced T1Wi Sequences in Characterization of Suspicious Mammography Lesions
M. El-Samahy (2017)
10.2214/AJR.09.3534
Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
S. Partridge (2010)
10.1007/978-1-4939-2047-1_5
Evaluation of Response in Malignant Tumors Treated with Targeted Agents
Giuseppe Re (2015)
10.1111/1754-9485.12278
Recognising pitfalls in assessment of tumours by diffusion‐weighted MRI: A pictorial essay
B. Parameswaran (2015)
10.3978/j.issn.1000-9604.2015.03.04
Diffusion-tensor imaging as an adjunct to dynamic contrast-enhanced MRI for improved accuracy of differential diagnosis between breast ductal carcinoma in situ and invasive breast carcinoma.
Y. Wang (2015)
10.1259/bjro.20180049
Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role
J. Camps-Herrero (2019)
10.1259/bjr.20160739
Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.
N. Shaverdian (2017)
10.3889/oamjms.2020.3895
Differentiating Benign from Suspicious Vertebral Marrow Lesions Detected with Conventional Magnetic Resonance Imaging Using Apparent Diffusion Coefficient and Diffusion-Weighted Image
K. Mohson (2020)
Distortion-free diffusion MRI using an MRI-guided Tri-Cobalt 60 radiotherapy system: Sequence verification and preliminary clinical experience
Yu Gao (2018)
10.1007/s00117-013-2496-3
Multiparametrische Bildgebung mittels simultaner MR/PET
S. Gatidis (2013)
10.1016/J.EJRNM.2016.07.021
Assessment of hepatic focal lesions on top of cirrhotic liver using dynamic and diffusion weighted magnetic resonance imaging
Naglaa L. Debees (2016)
10.1053/j.seminoncol.2012.11.008
Imaging of neuroendocrine tumors.
David Leung (2013)
10.3390/ijms21113862
Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies
Jayant Patwa (2020)
10.1097/RLI.0000000000000028
Intravoxel Incoherent Motion Diffusion-Weighted Imaging of Pancreatic Neuroendocrine Tumors: Prediction of the Histologic Grade Using Pure Diffusion Coefficient and Tumor Size
E. Hwang (2014)
10.1016/j.mri.2013.12.008
Diffusion-weighted MR imaging for assessing synovitis of wrist and hand in patients with rheumatoid arthritis: a feasibility study.
Xubin Li (2014)
10.1183/13993003.00190-2018
Lung cancer staging: a concise update
R. Rami‐Porta (2018)
10.1016/j.compbiomed.2016.09.022
T2-adjusted computed diffusion-weighted imaging: A novel method to enhance tumour visualisation
Lin Cheng (2016)
10.1016/j.mric.2014.04.004
Hepatic MR imaging techniques, optimization, and artifacts.
Flavius F Guglielmo (2014)
10.1148/radiol.2020191016
Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease.
Faraz Farhadi (2020)
10.4103/1110-208X.194381
Role of MRI diffusion in the diagnosis of uterine cervical carcinoma
E. Samy (2016)
10.1016/j.soc.2018.02.002
Imaging for Peritoneal Metastases.
R. N. Low (2018)
10.1007/s00261-019-02030-2
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation
Tim A Labeur (2019)
10.1097/MOU.0000000000000215
The role of multi-parametric MRI in loco-regional staging of men diagnosed with early prostate cancer
M. B. Appayya (2015)
10.1093/jncimonographs/lgv014
Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment.
M. Jacobs (2015)
10.1088/1361-6560/ab2c7c
IPEM Topical Report: A 2018 IPEM survey of MRI use for external beam radiotherapy treatment planning in the UK.
R. Speight (2019)
10.1007/978-3-030-14442-5
MRI for Radiotherapy
G. Liney (2019)
10.2214/AJR.09.3557
Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
I. Song (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar